| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-002-1027-0 |
| P698 | PubMed publication ID | 11981600 |
| P50 | author | Eric C. Donny | Q42409544 |
| Thomas Eissenberg | Q55536590 | ||
| P2093 | author name string | Maxine L Stitzer | |
| George E Bigelow | |||
| Sharon L Walsh | |||
| P433 | issue | 2 | |
| P921 | main subject | opioid | Q427523 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 202-212 | |
| P577 | publication date | 2002-03-13 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans | |
| P478 | volume | 161 |
| Q27692040 | A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice |
| Q36806539 | Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities |
| Q38885405 | Buprenorphine dosing choices in specific populations: review of expert opinion |
| Q51904834 | Buprenorphine treatment: factors and first-hand experiences for providers to consider. |
| Q37801439 | Buprenorphine‐Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment |
| Q36248580 | Clinical care of the HIV-infected drug user |
| Q44335633 | Consistent adherence to guidelines improves opioid dependent patients' first year outcomes |
| Q43455388 | Effect of Methadone Dose on Maintenance Treatment and Health Consequences Among Heroin Addicts in South China |
| Q37827079 | Effect of methadone maintenance treatment on heroin craving, a literature review |
| Q44334152 | Evaluation of buprenorphine dosage adequacy in opioid receptor agonist substitution therapy for heroin dependence: first use of the BUprenorphine-naloxone Dosage Adequacy eVAluation (BUDAVA) questionnaire |
| Q36628470 | Evidenced-based treatment of opioid-dependent patients |
| Q37692309 | High dose versus moderate dose methadone maintenance: is there a better outcome? |
| Q64319847 | Historical Review: Opiate Addiction and Opioid Receptors |
| Q36791973 | Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania |
| Q100465301 | Improving translation of animal models of addiction and relapse by reverse translation |
| Q34136977 | Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications. |
| Q39200931 | Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians |
| Q38111473 | Medications for substance use disorders |
| Q33729687 | Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings |
| Q52301876 | Methadone in the chronic pain patient with a substance use disorder. |
| Q37730680 | Methadone maintenance dosing guideline for opioid dependence, a literature review |
| Q36735035 | Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study |
| Q64287321 | Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China |
| Q44338048 | Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation |
| Q92527205 | Opioid use disorder |
| Q44346900 | Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects |
| Q42660244 | Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects |
| Q35454866 | Pharmacologic treatments for opioid dependence: detoxification and maintenance options |
| Q41990976 | Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment |
| Q36959135 | Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. |
| Q55176069 | Status Investigation of Outpatients Receiving Methadone Maintenance Treatment (MMT) in Shanghai from 2005 to 2016. |
| Q34652629 | The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales |
| Q35454891 | Therapeutic options and challenges for substances of abuse. |
| Q35053957 | There is no age limit for methadone: a retrospective cohort study |
| Q37117193 | Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV. |
| Q34455253 | Who uses methadone services in China? Monitoring the world's largest methadone programme |
Search more.